Leading AI with Purpose: From Vision to Measurable Value in Healthcare
Artificial intelligence is no longer a distant promise for healthcare. From accelerating drug discovery to improving clinical decision-making and optimizing...
Arcera Celebrates International Women’s Day 2026: The Ripple Makers of Arcera
Every action creates a ripple, and at Arcera, some of the most powerful ripples are created by the women who...
Driving innovation, quality, and trust through digitalization in manufacturing
Arcera has successfully implemented a new electronic Quality Management System (eQMS) consisting of six SmartSolve modules across 12 locations and corporate...
Arcera Life Sciences Convenes Global Healthcare Leaders in Abu Dhabi to Accelerate AI-Powered Healthcare Transformation Across the Middle East and beyond
Held during the annual “UAE Innovates” month, which aims to reinforce the UAE’s position as an international beacon of innovation,...
Arcera Life Sciences Drives Healthcare Innovation with Strategic ISPOR UAE Chapter Partnership and Novel Antibiotic Launch to Combat Antimicrobial Resistance in the UAE
Signed during the ISPOR UAE Chapter 2026 Conference in Abu Dhabi, the Memorandum of Understanding (MoU) coincides with the launch...
Ariprazol® Receives Qualification Release in the EU and Launches Sales in Latvia
Acino, part of Arcera, has obtained a qualification release for its prescription antipsychotic medicine Ariprazol® (aripiprazole) in the European Union,...
Arcera Life Sciences releases inaugural Sustainability Report
The 2024 report outlines Arcera’s current ESG initiatives and long-term ambitions, including a firm commitment to achieving full carbon neutrality...
AriBio and Arcera Sign Exclusive Licensing and Supply Agreements for Investigational Drug for Alzheimer’s Disease
Seongnam-si, South Korea and Abu Dhabi, UAE – June 10, 2025 – AriBio Co., Ltd. (“AriBio”), a South Korean biopharmaceutical company...
Achieving Level 1 B-BBEE status in South Africa for the sixth year in a row
For the sixth consecutive year, Acino has achieved Level 1 Broad-Based Black Economic Empowerment (B-BBEE) contributor status in South Africa.